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Introduction
Axons are indispensable for neuronal function but degenerate early in nervous system disorders ( Conforti et al., 2007a ) . Distal stumps of injured axons undergo Wallerian degeneration ( Waller, 1850 ) , a regulated, nonapoptotic death program that models disease processes ( Coleman, 2005 ) .
The slow Wallerian degeneration ( Wld S ) gene dominantly delays Wallerian degeneration 10-fold ( Mack et al., 2001 ; Ferri et al., 2003 ; Samsam et al., 2003 ; Coleman, 2005 ) . Wld S was identifi ed by positional cloning ( Coleman et al., 1998 ; Conforti et al., 2000 ) and replicates the protective phenotype in transgenic (Tg) mice ( Mack et al., 2001 ) , rats, and Drosophila melanogaster ( Adalbert et al., 2005 ; Hoopfer et al., 2006 ; MacDonald et al., 2006 ) . It fuses the N-terminal 70 amino acids (N70) of multiubiquitination factor Ube4b in frame to the NAD + -synthesizing enzyme nicotinamide mononucleotide adenylyl transferase 1 (Nmnat1), separated by a short Wld18 linker sequence. The parent proteins are unchanged. Wld S also delays axon degeneration in some diseases indicating similar mechanisms, particularly when axonal transport is blocked ( Coleman, 2005 ) .
Understanding how Wld S protects axons should help exploit its therapeutic potential and reveal the degenerative mechanism. In this study, we address the protein domains required in vivo and their roles. Overexpressing Nmnat1 in Tg mice is not suffi cient to protect axons ( Conforti et al., 2007b ) , but in lentiviral-transduced primary culture, protection has been reported ( Araki et al., 2004 ; Wang et al., 2005 ) . Thus, the N-terminal 88 amino acids are required in vivo, and primary culture experiments do not replicate the protective mechanism fully. However, the specifi c necessary sequences and their roles remain unknown. Moreover, reports that Nmnat1 blocks other types of T he slow Wallerian degeneration (Wld S ) protein protects injured axons from degeneration. This unusual chimeric protein fuses a 70 -amino acid N-terminal sequence from the Ube4b multiubiquitination factor with the nicotinamide adenine dinucleotide -synthesizing enzyme nicotinamide mononucleotide adenylyl transferase 1. The requirement for these components and the mechanism of Wld S -mediated neuroprotection remain highly controversial. The Ube4b domain is necessary for the protective phenotype in mice, but precisely which sequence is essential and why are unclear. Binding to the AAA adenosine triphosphatase valosin-containing protein (VCP)/p97 is the only known biochemical property of the Ube4b domain. Using an in vivo approach, we show that removing the VCP-binding sequence abolishes axon protection. ( Fig. 1 A ; Samsam et al., 2003 ) . Line 1 homozygotes expressed similar levels to Wld S heterozygotes. Line 2 could not breed to homozygosity. Hemizygotes expressed slightly less, but still at a level where Wld S delays axon degeneration signifi cantly ( Mack et al., 2001 ). Nmnat activity matched or exceeded that in Wld S ( Fig. 1 E ) , and lumbar spinal cord motor neurons, whose axons in the sciatic nerve we lesioned, express the protein ( Fig. 1 D ) . The ⌬ N16Wld S variant showed a clear cytoplasmic signal, with no signifi cant difference in neurodegeneration in vivo without enzyme activity contrasts with primary culture data on axon degeneration, so a classical mammalian in vivo approach is needed to resolve this ( Araki et al., 2004 ; Zhai et al., 2008 ) .
N70 binds AAA ATPase valosin-containing protein (VCP) through a VCP-binding motif (VBM) in its N-terminal 16 amino acids (N16; Boeddrich et al., 2006 ; Morreale et al., 2009 ). In nuclei, in which Wld S is most easily visualized, VCP infl uences local Wld S targeting ( Wilbrey et al., 2008 ) . Recent data indicate that Wld S can function in cytoplasm ( Beirowski et al., 2009 ) , in which VCP is extremely abundant. Thus, VCP interaction also likely affects local targeting of cytoplasmic Wld S . Early embryonic lethality precludes testing a role for VCP in null mice ( Muller et al., 2007 ) . Thus, we generated Tg mice expressing variant Wld S with altered VCP-binding properties and lesioned their nerves. In view of the controversies over Nmnat activity, we also generated enzyme-dead Tg mice. S (line 1), and ATX3Wld S (line 6). The graph shows integrated band intensities of nuclear and cytoplasmic fractions normalized to H1 and ␤ -actin, respectively. These normalized fi gures were then expressed as a percentage of the total homogenate signal and normalized to the same respective markers (mean ± SD; n = 3). Statistical analysis was performed on the nuclear versus supernatant ratio using a Mann-Whitney test followed by a Bonferroni post-hoc test. (D) Immunofl uorescence of lumbar spinal cord sections with Wld18 (red) and DAPI. Motor and interneuron nuclear signals in Tg ⌬ N16Wld S (i -iv) and ATX3Wld S (v -viii) show similar strength and distribution as Wld S heterozygotes. Identical laser intensities and camera settings were used for each image. (E and F) Transgene products are enzymatically active. Nmnat activity is very signifi cantly increased compared with wild-type (WT) brains in hemizygotes and homozygotes of all expressing Tg lines as well as Wld S heterozygotes. Mean ± SD; *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bars, 10 μ m.
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In contrast, ⌬ N16Wld S was indistinguishable from wild type. Line 1 homozygotes and line 2 hemizygotes showed 2.3 ± 0.2% and 0.9 ± 0.2% surviving axons, respectively ( Fig. 2, a -d ; and Fig. S1 ). Axons lost continuity, as assessed by crossing to YFP-H Tg mice ( Beirowski et al., 2004 ) , by 3 d ( Fig. 2, g and h ) , which is a low stringency test ruling out even a weak protective phenotype. Axons in Wld S heterozygotes maintain continuity even at 5 -14 d ( Fig. 3 ) . Finally, ultrastructural experiments confi rmed that axons of ⌬ N16Wld S mice retained little, if any, normal cytoskeleton and organelles after 3 d ( Fig. 2, i -l ) . Thus, N16, which contains a VBM, is essential for Wld S to delay Wallerian degeneration.
Replacing the VCP-binding site with the Atx-3 sequence restored strong axon protection similar to Wld S . 5 d after nerve lesion, lines 1 and 6 showed highly signifi cant structural preservation on semithin sections and retained axon continuity similar to Wld S heterozygotes ( We then replaced N16 with a 16 -amino acid VCP-binding sequence from polyglutamine protein ataxin-3 (Atx-3; 277 -291 plus start Met, ATX3) sharing only fi ve residues ( Fig. S1 ; Boeddrich et al., 2006 ) . At least 5 of 12 lines expressed protein, and most experiments used line 1 and 6 homozygotes. Again, we confi rmed protein expression and enzyme activity similar to or exceeding Wld S heterozygotes ( Fig. 1 ) . Despite some variability, subcellular localization of ATX3Wld S was not signifi cantly different from Wld S or ⌬ N16Wld S ( n = 3; Fig. 1 C ) , and the protein was in neuronal nuclei in the lumbar spinal cord ( Fig. 1 D , v -vii) .
Effect of the VCP-binding region on phenotype 5 d after sciatic nerve lesion, Wld S heterozygotes retained 69.7 ± 1.8% of axons with normal cytoskeleton, unswollen mitochondria, and a regular myelin sheath of normal thickness compared with only 1.2 ± 0.4% in wild-type mice ( Fig. 2 and Fig. S1 ). remained in wild-type nerves. We then confi rmed that lesioned axons and their neuromuscular synapses remained functional for at least 3 d. Evoked action potentials in tibial nerve/fl exor digitorum brevis (FDB) preparations provoked robust contractile and electromyographic responses ( Fig. 4 A and Video 1, available at
We then applied more stringent tests to verify that ATX3-Wld S mice have a full Wld S phenotype. 14 d after sciatic lesion, distal axons on semithin sections were structurally preserved, as in Wld S (P > 0.05). In whole-mount nerves, many YFP-H -labeled axons retained continuity ( Fig. 3 B and Fig. S1 ). Little but debris 
Nmnat enzyme activity is required for the

Wld S phenotype
Having shown that N16 is necessary for the Wld S phenotype in mice, we then tested the requirement for Nmnat activity in vivo and whether N16 and other N-terminal sequences, including Wld18, are sufficient. We made Tg mice expressing enzyme-dead Wld S (W258A; Fig. S1 ) but retaining all N-terminal sequences.
Tg-expressing lines 2 and 4 showed no increase in brain Nmnat activity over wild type, whereas activity in Wld S heterozygotes increased two-to threefold ( Fig. 5, A and C ) . As before, we confi rmed protein expression in motor neuron nuclei ( Fig. 5 B ) and we lesioned sciatic nerves. At the 3-d (low stringency) time point, homogeneous axoplasm and unswollen mitochondria could no longer be identifi ed in semithin sections ( Fig. 5 D , i and ii) , and neither line retained axon continuity ( Fig. 5 D ,  v and vi) . The third expressing line showed similar wild-typelike behavior (unpublished data). In contrast, Wld S heterozygous http://www.jcb.org/cgi/content/full/jcb.200807175/DC1) that were absent in controls (Video 2). Immunostaining for preserved presynaptic structures of 3-d axotomized neuromuscular junction showed most endplates partially or fully occupied by motor nerve terminals connected to intramuscular motor axons ( Fig. 4 B ) . We then treated spinal cervical ganglia (SCG) explants from these mice with vincristine to confi rm these results using an assay in which axons are not cut ( Ravula et al., 2007 ) . As reported, Wld S protected these axons ( Wang et al., 2001 ; Conforti et al., 2007b ) . Consistent with our in vivo data, ⌬ N16Wld S neurites degenerated at a wild-type rate, whereas ATX3Wld S neurites remained largely intact 5 d after vincristine application (Fig. S2) .
In summary, the Atx-3 -derived VCP-binding sequence restores axon protective properties to ⌬ N16Wld S that are indistinguishable from Wld S in terms of structure, long-term survival, and axonal and synaptic function. Collectively, these results strongly support a role of the VBM in Wld S -mediated axon protection. mice expressing a similar level of Wld S protein showed strong axon protection ( Fig. 5 D , iii; and Fig. S1 ).
We confi rmed rapid degeneration of injured W258AWld S neurites in SCG explant cultures and added 1 mM exogenous NAD + either 24 or 0 h before cutting. As we previously found in wild-type neurites ( Conforti et al., 2007b ) , neither treatment altered the rate of degeneration (Fig. S3 A, (Fig. S3 B) . These data suggest that NAD + synthesis is required for the Wld S phenotype, but the incomplete reversion also suggests a need to consider other actions of Nmnat1 and/or other downstream metabolites. Alternatively, NAD + may be tightly regulated at specifi c loci in a way that the whole cell measurements do not refl ect.
Finally, we tested whether Nmnat1 chaperone activity contributes to axon protection by Wld S . Chaperone activity in the W258A mutant protein was similar to that reported for enzymedead Nmnat ( n = 3; Zhai et al., 2008 ; and unpublished data) , but as the mice show no axon protection, this is unlikely to be sufficient for the Wld S phenotype. By refi ning the N-terminal sequence needed for Wld S protein to preserve injured axons in mice and showing that Nmnat enzyme activity is also required to protect axons in vivo, we conclude that Wld S protects axons through a mechanism involving both of its parts. The absence of axon protection in ⌬ N16Wld S mice confi rms and extends our earlier data that Nmnat1 cannot substitute for Wld S protein at a similar expression level ( Conforti et al., 2007b ). The accompanying paper shows that the two proteins are also not equivalent in Drosophila (see Avery et al. on p. 501 of this issue). However, Nmnat activity is required, and in Wld S , it works together with the N-terminal VCP-binding sequence to protect axons. The function of N16 now holds essential clues as to where this enzyme activity is needed and why, and it will be interesting to fi nd out whether other changes or additions to Nmnat1 can make it protective in vivo.
The only known biochemical property of N16 is binding VCP ( Laser et al., 2006 ) . The VBM is highly conserved among vertebrates and some invertebrates ( Morreale et al., 2009 ), including Drosophila , which could help explain how murine Wld S can function there through a mechanism involving VCP ( Avery et al., 2009 ) . At the cellular level, recent data indicate that Wld S can function outside nuclei ( Beirowski et al., 2009 ), so we tested whether N16 binding to VCP (which is abundant in the cytoplasm as well as the nucleus) tethers some Wld S in the cytoplasm. ⌬ N16 variant is abundant in cytoplasm ( Fig. 1 C ) , indicating that the functional importance of N16 is not solely to retain the protein in the cytoplasm. Instead, we propose a fi ner targeting role. As N16 binding to VCP infl uences local targeting of Wld S within nuclei ( Wilbrey et al., 2008 ) , it likely has a similar local effect in cytoplasm. Thus, the critical function of N16 may be local targeting of Nmnat1 to a cytoplasmic site where it is needed for axon protection.
Such a model may explain why overexpressing wild-type Nmnat1 without N16 fails to produce any Wld S phenotype in Tg mice ( Conforti et al., 2007b ) , whereas overexpression in lentiviraltransduced cultures or in Drosophila does reproduce the phenotype to some extent ( Araki et al., 2004 ; Hoopfer et al., 2006 ; MacDonald et al., 2006 ) . In higher expressing systems with shorter axons, Nmnat1 may reach levels at which focal targeting becomes unnecessary. However, high Nmnat1 expression levels could also trigger unrelated mechanisms.
The local targeting model raises two important questions: what is the critical site, and what does Nmnat1 do there? A local bioenergetics mechanism for NAD + within mitochondria has been proposed ( Wang et al., 2005 ) . However, the ability of Wld S to maintain axonal NAD + and ATP levels could be an effect of axon survival rather than a cause, and how VCP binding and N16 fi t such a model is not clear. Further investigations of VCP in mitochondria could shed light on this issue ( Braun et al., 2006 ). An alternative location that does connect VCP and NAD + is the ER. VCP is particularly abundant here ( Ye et al., 2005 ) , and NAD + is a key upstream regulator of calcium signaling in this organelle through enzymes such as CD38 ( Macgregor et al., 2007 ) . NAD + is also a substrate for the sirtuin family of histone deacetylases ( Yang and Sauve, 2006 ) and for the ADP ribosylase PARP-1 ( Kim et al., 2005 ) , and Nmnat protects against reactive oxygen species ( Press and Milbrandt, 2008 ) . A Sirt1-mediated mechanism ( Araki et al., 2004 ) is not supported by subsequent data ( Wang et al., 2005 ; Conforti et al., 2007b ; Avery et al., 2009 ), but these other possibilities remain plausible. However, a chaperone-mediated mechanism for axon protection ( Zhai et al., 2008 ) is not supported by our data.
Other functions of VCP include roles in the cell cycle, homotypic membrane fusion, nuclear envelope reconstruction, postmitotic Golgi reassembly, DNA damage response, suppression of apoptosis, ER-associated protein degradation, and ubiquitindependent protein degradation ( Watts et al., 2004 ) . Thus, if the critical function of N16 is binding to VCP, one or more of these sites 
Materials and methods
Generation of Tg mice
The ⌬ N16Wld S Tg construct was generated as previously reported ( Mack et al., 2001 ; Conforti et al., 2007b ) using the forward PCR primer 5 Ј -TAGCCC AAGCTT TAGAGGAAAGCG ATG CTTGCTGGTGGA-CAGACCTC-3 Ј (5 Ј HindIII tag and start codon underlined). For the ATX3Wld S construct, the primer 5 Ј -AGCCC AAGCTT TAGAGGAAAGCG-ATG ACTTCAGAAGAGCTTCGGAAGAGACGAGAAGCCTACTTGAAAAA CTT-GCTGGTGGACAGACCT -3 Ј (5 Ј HindIII tag and start codon underlined, Atx-3 sequences in bold, and Wld S sequences in bold and italic) and its reverse complement were annealed and mixed with linearized ⌬ N16Wld S . The mix was used as a template for PCR with the reverse primer that has been previously described ( Mack et al., 2001 ; Conforti et al., 2007b ) and the forward primer 5 Ј -AGCCC AAGCTT TAGAGGAAAGCG ATG ACTTC-3 Ј (5 Ј HindIII tag and start codon underlined). For the W258AWld S construct, tryptophan 258 of Wld S was mutated to an alanine using the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies) with the primer 5 Ј -GCGTGCCCAACTTG GCG AAGATGGAGGAC-3 Ј and its reverse complementary primer (W → A mutation underlined).
Pronuclear injection of the EcoRI -NdeI fragments (Fig. S1 ) into an F1 C57BL-CBA strain was performed by the in-house Gene Targeting Facility. Animal work was performed in accordance with the 1986 Animals (Scientifi c Procedures) Act under project licence PPL 80/1778.
Genotyping
Tg mice were identifi ed by Southern blotting as described previously ( Conforti et al., 2007b ) . YFP-H mice ( Feng et al., 2000 ) were obtained from The Jackson Laboratory and genotyped by Southern blotting (YFP probe generated by PCR from YFP-H mouse genomic DNA using the primers 5 Ј -CGAACTCCAGCAGGACCATGTGAT-3 Ј and 5 Ј -CTT CTTCAAGGACGACGGCAACTACAAG-3 Ј ).
Western blotting and Nmnat enzyme activity assay
Western blotting and Nmnat enzyme activity assays of sagittally divided half brains were performed as described previously ( Conforti et al., 2007b ) . Subcellular fractionation of the nuclear and cytoplasmic compartments was performed as described previously ( Beirowski et al., 2009 ) . For these experiments, Wld S heterozygotes, ⌬ N16Wld S line 1, and ATX3Wld S line 6 mice were used. In addition to Wld18 (1:2,000), mouse monoclonal anti -histone H1 (1:500; Millipore) and mouse monoclonal anti -␤ -actin (1:5,000; Abcam) were used as loading controls for the nuclear and the cytoplasmic fraction, respectively. All subcellular pellets were resuspended in the same volume as the starting total homogenate. Identical volumes of each fraction were loaded on the gels. For quantifi cation, Western blot band intensities were determined with ImageJ software (National Institutes of Health) and analyzed as described in the fi gure legends.
Statistical analysis was performed using one-way analysis of variance followed by Dunnett ' s t post-hoc test or, when this was not applicable, by Kruskall-Wallis analysis followed by Mann-Whitney tests.
Immunocytochemistry 20-μ m cryostat lumbar spinal cord sections of 4% paraformaldehyde perfusion-fi xed mice were immunostained for Wld18 and imaged as described previously ( Conforti et al., 2007b ) . Isolated FDB muscles were whole-mount immunostained for neurofi lament and/or SV2, and acetylcholine receptors at motor endplates were counterstained with TRITC -␣ -bungarotoxin and imaged as described previously ( Gillingwater et al., 2002 ) .
Acquisition and processing of images
Bright fi eld images were acquired on a microscope (IX8I; Olympus) coupled to a digital camera (U-TV 0.5XC; Olympus) using AnalySIS software (Soft Imaging System, GmbH). The objectives used were UPlanFI 4 × NA 0.13, UPLanFI 10 × NA 0.3, LCPlanFI 20 × NA 0.40 (all air objectives), and UPLanSApo oil immersion 100 × NA 1.40. Confocal fl uorescent images were acquired using a confocal microscope system (LSM 510 Meta; Carl Zeiss, Inc.) built around an Axiovert 200 (Carl Zeiss, Inc.), and z series were merged using algorithms from LSM Software Release 3.2 (Carl Zeiss, Inc.). For colocalization analysis, the multitrack confi guration mode was applied to avoid signal cross talk between individual fl uorophores. The objectives used were Plan-Neofl uar 20 × NA 0.5 and oil immersion Plan-Apochromat 63 × NA 1.4. Tissue preparations were mounted in Vectashield medium (Vector Laboratories). The fl uorophores used were YFP could be important. VCP also has many associations with neurodegenerative disease as a component of intranuclear and cytoplasmic aggregates ( Kobayashi et al., 2007 ) , as the mutated gene in the rare neurological disorder inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia ( Watts et al., 2004 ) , and through binding to Atx-3 and other polyglutamine proteins ( Hirabayashi et al., 2001 ; Boeddrich et al., 2006 ) .
As there are no null or conditional null VCP mice, VCPindependent mechanisms cannot be tested further using in vivo mouse experiments. We cannot rule out a role for other amino acids in common between the Atx-3 -derived VCP-binding sequence and N16 or an infl uence on Wld S turnover. However, in Drosophila , where targeted RNAi in specifi c neurons overcomes lethality, VCP knockdown signifi cantly weakens the Wld S phenotype ( Avery et al., 2009 ). Collectively, these data strongly suggest that VCP binding is the critical property of this sequence that is required for the phenotype.
Like other chimeric proteins, Wld S has a biological activity that requires both of its parts. In other cases, this can be the result of a conformational change that confers a new property such as affi nity for a different receptor in the case of a ligand ( Campbell et al., 1997 ) . The combination of two different proteins to form a chimera often arises from chromosome translocations or gene duplications and has evolutionary relevance. Wld S arose in the laboratory mouse, so it is not the result of generations of adaptive mutations. Nevertheless, this is another intriguing example of how protein domains can be combined to produce a completely new function.
The impressive correlation between the phenotypes of Wld S mice, rats, and Drosophila , each carrying the mouse cDNA, indicates that the degenerative pathway that it blocks is well conserved in evolution. Even in Drosophila , Nmnat1 cannot fully substitute for Wld S in conferring axon protection, although a weak effect can be obtained from Nmnat1 over expression alone, maybe refl ecting higher expression levels reached in the fl y with the use of a different promoter ( MacDonald et al., 2006 ; Avery et al., 2009 ) . VCP-binding sequences are required for the full Wld S phenotype in Drosophila as well as in mice, and down-regulation of ter94, the Drosophila homologue of VCP, signifi cantly weakens the phenotype ( Avery et al., 2009 ) . These similarities validate Drosophila as a model to study axon degeneration and protection by Wld S and demonstrate how Drosophila experiments can provide information not easily obtainable in the mouse.
In summary, we show that N16, which contains a VBM, is necessary for Wld S to delay Wallerian degeneration, and this sequence acts together with Nmnat1 activity. In this study, we propose a new model for Wld S action that explains the requirement of both N-terminal Ube4b-derived sequence and Nmnat1 enzyme activity. Having strongly implicated VCP binding in the protective mechanism and having shown that VCP binding helps direct the subcellular distribution of Wld S , we suggest that the role of the N-terminal region is to deliver Nmnat activity to an important, specifi c subcellular site. Further studies are necessary to identify this specifi c site and to understand what Nmnat1 does there to produce the Wld S phenotype.
